We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The afterload-dependent peak efficiency of the isolated working rat heart is unaffected by streptozotocin-induced diabetes.
- Authors
June-Chiew Han; Soyeon Goo; Barrett, Carolyn J.; Mellor, Kimberley; Taberner, Andrew J.; Loiselle, Denis S.
- Abstract
Background Diabetes is known to alter the energy metabolism of the heart. Thus, it may be expected to affect the efficiency of contraction (i.e., the ratio of mechanical work output to metabolic energy input). The literature on the subject is conflicting. The majority of studies have reported a reduction of myocardial efficiency of the diabetic heart, yet a number of studies have returned a null effect. We propose that these discrepant findings can be reconciled by examining the dependence of myocardial efficiency on afterload. Methods We performed experiments on streptozotocin (STZ)-induced diabetic rats (7-8 weeks postinduction), subjecting their (isolated) hearts to a wide range of afterloads (40 mmHg to maximal, where aortic flow approached zero). We measured work output and oxygen consumption, and their suitably scaled ratio (i.e., myocardial efficiency). Results We found that myocardial efficiency is a complex function of afterload: its value peaks in the mid-range and decreases on either side. Diabetes reduced the maximal afterload to which the hearts could pump (105 mmHg versus 150 mmHg). Thus, at high afterloads (for example, 90 mmHg), the efficiency of the STZ heart was lower than that of the healthy heart (10.4% versus 14.5%) due to its decreased work output. Diabetes also reduced the afterload at which peak efficiency occurred (optimal afterload: 63 mmHg versus 83 mmHg). Despite these negative effects, the peak value of myocardial efficiency (14.7%) was unaffected by diabetes. Conclusions Diabetes reduces the ability of the heart to pump at high afterloads and, consequently, reduces the afterload at which peak efficiency occurs. However, the peak efficiency of the isolated working rat heart remains unaffected by STZ-induced diabetes.
- Subjects
DIABETES; IMMUNOSUPPRESSIVE agents; STREPTOZOTOCIN; ENDOCRINE diseases; METABOLISM
- Publication
Cardiovascular Diabetology, 2014, Vol 13, Issue 1, p1
- ISSN
1475-2840
- Publication type
Article
- DOI
10.1186/1475-2840-13-4